Fondaparinux: A potential new therapy for HIT
Kevin H.M. Kuo(University Health Network), Michael J. Kovacs(Western University)
Cited by 63
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162
Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis
|Blood|2015|129
Assessment of the Validity of the INR System for Patients with Liver Impairment
|Thrombosis and Haemostasis|1994|117